-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- Sutro Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $15.8 M.
- Sutro Biopharma, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $18.2 M.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $18.2 M, a 628% increase from 2022.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.5 M.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)